83 related articles for article (PubMed ID: 24628247)
1. Thiophene-based compounds as fluorescent tags to study mesenchymal stem cell uptake and release of taxanes.
Duchi S; Dambruoso P; Martella E; Sotgiu G; Guerrini A; Lucarelli E; Pessina A; Coccè V; Bonomi A; Varchi G
Bioconjug Chem; 2014 Apr; 25(4):649-55. PubMed ID: 24628247
[TBL] [Abstract][Full Text] [Related]
2. Paclitaxel is incorporated by mesenchymal stromal cells and released in exosomes that inhibit in vitro tumor growth: a new approach for drug delivery.
Pascucci L; Coccè V; Bonomi A; Ami D; Ceccarelli P; Ciusani E; Viganò L; Locatelli A; Sisto F; Doglia SM; Parati E; Bernardo ME; Muraca M; Alessandri G; Bondiolotti G; Pessina A
J Control Release; 2014 Oct; 192():262-70. PubMed ID: 25084218
[TBL] [Abstract][Full Text] [Related]
3. Redox-sensitive micelles self-assembled from amphiphilic hyaluronic acid-deoxycholic acid conjugates for targeted intracellular delivery of paclitaxel.
Li J; Huo M; Wang J; Zhou J; Mohammad JM; Zhang Y; Zhu Q; Waddad AY; Zhang Q
Biomaterials; 2012 Mar; 33(7):2310-20. PubMed ID: 22166223
[TBL] [Abstract][Full Text] [Related]
4. Human CD14+ cells loaded with Paclitaxel inhibit in vitro cell proliferation of glioblastoma.
Bonomi A; Lisini D; Navone SE; Frigerio S; Dossena M; Ciusani E; Rampini P; Marfia G; Coccè V; Cavicchini L; Sisto F; Parati E; Mantegazza R; Rimoldi M; Rizzetto M; Alessandri G; Pessina A
Cytotherapy; 2015 Mar; 17(3):310-9. PubMed ID: 25457277
[TBL] [Abstract][Full Text] [Related]
5. Human skin-derived fibroblasts acquire in vitro anti-tumor potential after priming with Paclitaxel.
Pessina A; Coccè V; Bonomi A; Cavicchini L; Sisto F; Ferrari M; Ciusani E; Navone S; Marfia G; Parati E; Alessandri G
Anticancer Agents Med Chem; 2013 Mar; 13(3):523-30. PubMed ID: 22931415
[TBL] [Abstract][Full Text] [Related]
6. Site-specifically traced drug release and biodistribution of a paclitaxel-antibody conjugate toward improvement of the linker structure.
Safavy A; Georg GI; Vander Velde D; Raisch KP; Safavy K; Carpenter M; Wang W; Bonner JA; Khazaeli MB; Buchsbaum DJ
Bioconjug Chem; 2004; 15(6):1264-74. PubMed ID: 15546192
[TBL] [Abstract][Full Text] [Related]
7. Human amniotic mesenchymal stromal cells (hAMSCs) as potential vehicles for drug delivery in cancer therapy: an in vitro study.
Bonomi A; Silini A; Vertua E; Signoroni PB; Coccè V; Cavicchini L; Sisto F; Alessandri G; Pessina A; Parolini O
Stem Cell Res Ther; 2015 Aug; 6(1):155. PubMed ID: 26315881
[TBL] [Abstract][Full Text] [Related]
8. Human bone marrow-derived mesenchymal stromal cells expressing S-TRAIL as a cellular delivery vehicle for human glioma therapy.
Menon LG; Kelly K; Yang HW; Kim SK; Black PM; Carroll RS
Stem Cells; 2009 Sep; 27(9):2320-30. PubMed ID: 19544410
[TBL] [Abstract][Full Text] [Related]
9. Effect of canine mesenchymal stromal cells loaded with paclitaxel on growth of canine glioma and human glioblastoma cell lines.
Bonomi A; Ghezzi E; Pascucci L; Aralla M; Ceserani V; Pettinari L; Coccè V; Guercio A; Alessandri G; Parati E; Brini AT; Zeira O; Pessina A
Vet J; 2017 May; 223():41-47. PubMed ID: 28671070
[TBL] [Abstract][Full Text] [Related]
10. Cell-mediated drug delivery by gingival interdental papilla mesenchymal stromal cells (GinPa-MSCs) loaded with paclitaxel.
Brini AT; Coccè V; Ferreira LM; Giannasi C; Cossellu G; Giannì AB; Angiero F; Bonomi A; Pascucci L; Falchetti ML; Ciusani E; Bondiolotti G; Sisto F; Alessandri G; Pessina A; Farronato G
Expert Opin Drug Deliv; 2016 Jun; 13(6):789-98. PubMed ID: 26986001
[TBL] [Abstract][Full Text] [Related]
11. Mechanistic study of the covalent loading of paclitaxel via disulfide linkers for controlled drug release.
Yuan L; Chen W; Hu J; Zhang JZ; Yang D
Langmuir; 2013 Jan; 29(2):734-43. PubMed ID: 23252889
[TBL] [Abstract][Full Text] [Related]
12. Dual targeting folate-conjugated hyaluronic acid polymeric micelles for paclitaxel delivery.
Liu Y; Sun J; Cao W; Yang J; Lian H; Li X; Sun Y; Wang Y; Wang S; He Z
Int J Pharm; 2011 Dec; 421(1):160-9. PubMed ID: 21945183
[TBL] [Abstract][Full Text] [Related]
13. Adipose tissue-derived stromal cells primed in vitro with paclitaxel acquire anti-tumor activity.
Bonomi A; Coccè V; Cavicchini L; Sisto F; Dossena M; Balzarini P; Portolani N; Ciusani E; Parati E; Alessandri G; Pessina A
Int J Immunopathol Pharmacol; 2013; 26(1 Suppl):33-41. PubMed ID: 24046947
[TBL] [Abstract][Full Text] [Related]
14. Stepwise orthogonal click chemistry toward fabrication of paclitaxel/galactose functionalized fluorescent nanoparticles for HepG2 cell targeting and delivery.
Lai CH; Chang TC; Chuang YJ; Tzou DL; Lin CC
Bioconjug Chem; 2013 Oct; 24(10):1698-709. PubMed ID: 23987828
[TBL] [Abstract][Full Text] [Related]
15. Preparation and in vitro properties of redox-responsive polymeric nanoparticles for paclitaxel delivery.
Song N; Liu W; Tu Q; Liu R; Zhang Y; Wang J
Colloids Surf B Biointerfaces; 2011 Oct; 87(2):454-63. PubMed ID: 21719259
[TBL] [Abstract][Full Text] [Related]
16. Visualizing of the cellular uptake and intracellular trafficking of exosomes by live-cell microscopy.
Tian T; Wang Y; Wang H; Zhu Z; Xiao Z
J Cell Biochem; 2010 Oct; 111(2):488-96. PubMed ID: 20533300
[TBL] [Abstract][Full Text] [Related]
17. Mesenchymal stem cell: an efficient mass producer of exosomes for drug delivery.
Yeo RW; Lai RC; Zhang B; Tan SS; Yin Y; Teh BJ; Lim SK
Adv Drug Deliv Rev; 2013 Mar; 65(3):336-41. PubMed ID: 22780955
[TBL] [Abstract][Full Text] [Related]
18. Human mesenchymal stem cells exploit the immune response mediating chemokines to impact the phenotype of glioblastoma.
Motaln H; Gruden K; Hren M; Schichor C; Primon M; Rotter A; Lah TT
Cell Transplant; 2012; 21(7):1529-45. PubMed ID: 22554389
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and biological evaluation of paclitaxel-C225 conjugate as a model for targeted drug delivery.
Safavy A; Bonner JA; Waksal HW; Buchsbaum DJ; Gillespie GY; Khazaeli MB; Arani R; Chen DT; Carpenter M; Raisch KP
Bioconjug Chem; 2003; 14(2):302-10. PubMed ID: 12643740
[TBL] [Abstract][Full Text] [Related]
20. Novel cathepsin B-sensitive paclitaxel conjugate: Higher water solubility, better efficacy and lower toxicity.
Liang L; Lin SW; Dai W; Lu JK; Yang TY; Xiang Y; Zhang Y; Li RT; Zhang Q
J Control Release; 2012 Jun; 160(3):618-29. PubMed ID: 22410114
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
